Silodosin

Rapaflo

Silodosin(Rapaflo) is an α1-adrenoceptor antagonist with high uroselectivity. Silodosin causes practically no orthostatic hypotension (in contrast to other α1 blockers). Since Silodosin is a highly selective inhibitor of the α1A adrenergic receptor, it causes practically no orthostatic hypotension (in contrast to other α1 blockers).

目录号
EY2258
EY2258
EY2258
纯度
99.41%
99.41%
99.41%
规格
5 mg
10 mg
50 mg
原价
390
640
2470
售价
390
640
2470
库存
现货
现货
现货
订购
订购
订购
订购
订购
订购
  • 生物活性

    Silodosin(Rapaflo) is an α1-adrenoceptor antagonist with high uroselectivity. Silodosin causes practically no orthostatic hypotension (in contrast to other α1 blockers). Since Silodosin is a highly selective inhibitor of the α1A adrenergic receptor, it causes practically no orthostatic hypotension (in contrast to other α1 blockers).

  • 体外研究

  • 体内研究

  • 激酶实验

  • 细胞实验

  • 动物实验

  • 不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)

    动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 AKm系数


    例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。


  • 参考文献

    [1] Martin Hennenberg, et al. Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle. PLoS One. 2012; 7(11): e50904. Published online 2012 Nov 30. doi: 10.1371/journal.pone.0050904.
    [2] Kazuhisa Hagiwara,et al. Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study. Biomed Res Int. 2016; 2016: 4975851. Published online 2016 Apr 18. doi: 10.1155/2016/4975851.
    [3] Takashi Kawahara,et al. Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation. Am J Cancer Res. 2015; 5(10): 2959–2968. Published online 2015 Sep 15.

    分子式
    C25H32F3N3O4
    分子量
    495.53
    CAS号
    160970-54-7
    储存方式
    -20 ℃长期冷藏储存。冰袋运输
    溶剂(常温)
    DMSO
    99 mg/mL
    Water
    <1 mg/mL
    Ethanol
    99 mg/mL

    体内溶解度

  • Clinical Trial Information ( data from http://clinicaltrials.gov )

    注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。

  • 相关化合物库

  • 使用AMQUAR产品发表文献后请联系我们

相关推荐

X
  • 联系人 :
  • 收件地址 :
  • 电话号码 :
  • 单位名称 :
  • 产品货号 :
  • 产品规格 :
  • 发票抬头以及单位税号 :